NIGMS

May 17, 2012

Long live the therapeutic stem cells

Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.

By Leigh MacMillan
March 16, 2012

Colon cancer’s cellular crossroads

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

By VUMC News and Communications
March 2, 2012

‘Detangler’ binds, bends and cuts DNA

New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.

By Leigh MacMillan
February 15, 2012

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

By VUMC News and Communications
January 5, 2012

Meds’ benefits differ in dialysis patients

By VUMC News and Communications
December 15, 2011

Divvying up chromosomes

Protein helps ensure proper division of chromosomes during cell division.

By VUMC News and Communications
December 15, 2011

Virus-linked cancer gets help from host

Host cell protein may be a target for strategies to limit spread of virus-induced squamous cell cancers.
By VUMC News and Communications
November 4, 2011

Let there be light and melatonin

Light and the hormone melatonin may play important roles in the developing brain.
By Leigh MacMillan
October 7, 2011

Heart protein may be target for colon cancer therapies

A protein critical in heart development may also play a part in colon cancer progression.
By VUMC News and Communications
1 … 18 19 20 21 22